Managing health problems in people with intellectual disabilities

BMJ

Volumn 337, Issue 7683, 2008, Pages 1408-1412

  Van Schrojenstein Lantman de Valk, Henny M J ^a,b   Walsh, Patricia Noonan ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Pepijn and Paulus Centre   (Netherlands)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEALTH PROMOTION; HUMAN; INTELLECTUAL IMPAIRMENT; MENTAL HEALTH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

COMMUNICATION; DELIVERY OF HEALTH CARE; HEALTH PROMOTION; HEALTH STATUS; HUMANS; INFORMED CONSENT; INTELLECTUAL DISABILITY; MEDICAL HISTORY TAKING; MENTAL HEALTH; PATIENT CARE PLANNING; PHYSICIAN-PATIENT RELATIONS;

EID: 57749185465     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a2507     Document Type: Review

References (24)

1. Cooper SA, Melville C, Morrison J. People with intellectual disabilities. BMJ 2004;329:414-5.
2. US Government. Healthy people 2010. Disability and secondary conditions. http://healthypeople.gov/document/HTML/Volume1/06Disability.htm
3. Pomona Project. Health indicators for people with intellectual disabilities. www.pomonaproject.org
4. Lennox N, Bain C, Rey-Conde T, Purdie D, Bush R, Pandeya N. Effects of a comprehensive health assessment programme for Australian adults with intellectual disability: a cluster randomized trial. Int J Epidemiol 2007;36:139-46.
5. Wullink M, van-Schrojenstein-Lantman-de-valk HM, Dinant GJ, Metsemakers JF. Prevalence of people with intellectual disability in the Netherlands. J Intellect Disabil Res 2007;51(pt 7):511-9.
6. Mont D. Measuring health and disability. Lancet 2007;369:1658-63.
7. Kwok H, Cheung PWH. Co-morbidity of psychiatric disorder and medical illness in people with intellectual disabilities. Curr Opin Psychiatry 2007;20:443-9.
8. Van-Schrojenstein-Lantman-De-Valk HM, Metsemakers JF, Haveman MJ, Crebolder HF. Health problems in people with intellectual disability in general practice: a comparative study. Fam Pract 2000;17:405-7.
9. Prasher V, Gomez G. Natural history of thyroid function in adults with Down syndrome - 10-year follow-up study. J Intellect Disabil Res 2007;51(pt 4):312-7.
10. Cooper SA, Smiley E, Morrison J, Williamson A, Allan L. Mental ill-health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry 2007:27-35.
11. Cooper SA, Smiley E, Morrison J, Allan L, Williamson A, Finlayson J, et al. Psychosis and adults with intellectual disabilities. Prevalence, incidence, and related factors. Soc Psychiatry Psychiatric Epidemiol 2007;42:530-6.
12. Strydom A, Livingston G, King M, Hassiotis A. Prevalence of dementia in intellectual disability using different diagnostic criteria. Br J Psychiatry 2007;191:150-7.
13. Melville CA, Hamilton S, Hankey CR, Miller S, Boyle S. The prevalence and determinants of obesity in adults with intellectual disabilities. Obes Rev 2007;8:223-30.
14. Bohmer CJ, Klinkenberg-Knol EC, Niezen-de-Boer MC, Meuwissen SG. Gastroesophageal reflux disease in intellectually disabled individuals: how often, how serious, how manageable? Am J Gastroenterol 2000;95:1868-72.
15. Cumella S, Ransford N, Lyons J, Burnham H. Needs for oral care among people with intellectual disability not in contact with Community Dental Services. J Intellect Disabil Res 2000;44(pt 1):45-52.
16. Nunn J, Freeman R, Anderson E, Carneiro LC, Carneiro MS, Formicola A, et al. Inequalities in access to education and healthcare. Eur J Dental Educ 2008;12:30-9.
17. Patja K, Eero P, Iivanainen M. Cancer incidence among people with intellectual disability. J Intellect Disabil Res 2001;45(pt 4):300-7.
18. Albanese A, Hopper NW. Suppression of menstruation in adolescents with severe learning disabilities. Arch Dis Child 2007;92:629-32.
19. Straetmans JM, van-Schrojenstein-Lantman-de-Valk HM, Schellevis FG, Dinant GJ. Health problems of people with intellectual disabilities: the impact for general practice. Br J Gen Pract 2007;57:64-6.
20. Emerson E. Poverty and people with intellectual disabilities. Ment Retard Dev Disabil Res Rev 2007;13:107-13.
21. Lennox N, Beange H, Davis R, Durvasula S, Edwards N, Graves P, et al. Management guidelines. Developmental disability. 2nd ed. Melbourne, Australia: Therapeutic Guidelines, 2005. www.tg.com.au/index.php?sectionid=100
22. Brylewski J, Duggan L. Anitpsychotic medication for challenging behaviour in people with learning disability. Cochrane Database Syst Rev 2004;(3):CD000377.
23. Tyrer P, Oliver-Africano PC, Ahmed Z, Bouras N, Cooray S, Deb S, et al. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet 2008;371:57-63.
24. Beavis J, Kerr M, Marson A. Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev 2007;(3):CD 005399.